Gross value added, AE046 Manufacture of pharmaceuticals, medicinal chemicals and botanical products, chained 2013 Q
Latest, 2024Q2.14BAnnual release
vs 2023−1.1%Q2.16B
High since 2013Q2.16B2023 · Banguat
Low since 2013Q1.27B2013 · Banguat
Recent years
- 2024Q2.14B−1.1% (worse)
- 2023Q2.16B+11.6% (better)
- 2022Q1.94B+3.4% (better)
- 2021Q1.87B+2.8% (better)
- 2020Q1.82B+11.4% (better)
- 2019Q1.64B+3.6% (better)
- 2018Q1.58B−0.8% (worse)
- 2017Q1.59B−0.4% (worse)
Full table
| Period | Value |
|---|---|
| 2024 | Q2,140.1 M |
| 2023 | Q2,163.5 M |
| 2022 | Q1,938.7 M |
| 2021 | Q1,874.9 M |
| 2020 | Q1,823.8 M |
| 2019 | Q1,636.7 M |
| 2018 | Q1,579.9 M |
| 2017 | Q1,592.1 M |
| 2016 | Q1,598.9 M |
| 2015 | Q1,486.4 M |
| 2014 | Q1,418.5 M |
| 2013 | Q1,273.0 M |
Related
- Economic activity (IMAE)Banguat159.91indexJul 2026+2.9%vs Jun
- Real GDPBanguatQ637.7B2025+4.3%vs 2024
- Quarterly real GDPBanguatQ164.4BQ1 2026+0.2%vs Q4 2025
- Nominal GDPBanguatQ947.0B2025+7.8%vs 2024